June 5, 2026 | European Renal Association 2026 Congress | Poster Presentation
Interim Results of a Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE101 in Healthy Volunteers
June 4, 2026 | European Renal Association 2026 Congress | Poster Presentation
A Phase 2, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of JADE101 in Participants with IgAN
November 8, 2025 | American Society of Nephrology Kidney Week 2025 | Poster Presentation
Nonclinical Safety Profile of JADE101
November 8, 2025 | American Society of Nephrology Kidney Week 2025 | Poster Presentation
Translational Framework to Predict Clinical Responses to APRIL Blockade for Development of JADE101
June 6, 2025 | European Renal Association 2025 Congress | Poster Presentation
Discovery and Characterization of JADE101